In addition, ANXA8 expression significantly correlated with features of breast cancer progression such as tumor grade, stage and lymph node infiltration, arising as a putative biomarker to identify ER-negative basal-like breast cancers (Rossetti et al., 2016). Here, ANXA8 is linked to breast carcinoma.